Alashkar, Ferras <br/><br/>
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.  [electronic resource] 

 -  Annals of hematology  Apr 2017 
 - 589-596 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-017-2924-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Cohort Studies<br/>Drug Administration Schedule<br/>Female<br/>Hemoglobinuria, Paroxysmal--blood<br/>Humans<br/>Male<br/>Meningococcal Infections--blood<br/>Meningococcal Vaccines--administration & dosage<br/>Middle Aged<br/>Rabbits<br/>Retrospective Studies<br/>Serologic Tests--methods<br/>Serum Bactericidal Test--methods<br/>Treatment Outcome